Liver function tests

1 paper

Latest

5 in 12 months

Research Square3 h

Empagliflozin Improves Muscle Weakness in a Patient with Suspected Glycogen Storage Myopathy: A Case Report

Preprint: case reportEmpagliflozin

Food & Nutrition Research9 Aug

SheVari4®, a proprietary root extract from Asparagus racemosus, ameliorates menopausal health: insights from a randomized, double-blind, placebo controlled clinical trial

Randomised trial in 60 peopleInterventions

BMJ Public Health5 Aug

Longitudinal retrospective cohort study to examine liver, cardiovascular and metabolic factors as predictors of all-cause mortality in a rural population in South-West Uganda

Cohort study of 7,896 peoplePopulations

Zhonghua Liu Xing Bing Xue Za Zhi22 Jan

Liver function and distribution of liver fibrosis in older adults aged 65 years and above in 18 longevity areas in China

Cross-sectional study of 5,403 peopleLiver fibrosis

Hepatology Communications1 Jan

Nicotinamide riboside enhances liver regeneration via the MCART1/ASB3 axis in obesity-compromised rats

Experiments in ratsNicotinamide riboside

ENDO 2025 Abstract23 Oct

SAT-661 Hepatic and Cardiovascular Outcomes of Patients with Metabolic Dysfunction-Associated Steatotic-Liver Disease and Diabetes Mellitus Type 2 Treated with Glucagon-Like Peptide 1 Agonists

Cohort study in peopleGLP-1 receptor agonists

ENDO 2025 Abstract23 Oct

SAT-661 1. Hepatic and Cardiovascular Outcomes of Patients with Metabolic Dysfunction-Associated Steatotic-Liver Disease and Diabetes Mellitus Type 2 Treated with Glucagon-Like Peptide 1 Agonists

Cohort study in peopleGLP-1 receptor agonists

Archives of Medical Science31 Jul

Assessing the impact of a wheat flour and baker's yeast restricted diet vs. calorie restriction in non-alcoholic fatty liver disease patients

Non-randomised trial in 243 peopleDietary restriction

Nature Reviews Gastroenterology & Hepatology29 Jul

Liver, ageing and disease

ReviewMechanisms

Trials2 Oct

A single-center, double-blind, randomized, placebo-controlled, two-arm study to evaluate the safety and efficacy of once-weekly sirolimus (rapamycin) on muscle strength and endurance in older adults following a 13-week exercise program